Publicaciones en colaboración con investigadores/as de Instituto Cajal (4)

2011

  1. Prospects for cannabinoid therapies in basal ganglia disorders

    British Journal of Pharmacology, Vol. 163, Núm. 7, pp. 1365-1378

2005

  1. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis

    Neurobiology of Disease, Vol. 20, Núm. 2, pp. 207-217

2002

  1. Blockade of cannabinoid CB1 receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity

    Journal of Neurochemistry, Vol. 82, Núm. 1, pp. 154-158

2001

  1. Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets

    European Journal of Neuroscience, Vol. 14, Núm. 11, pp. 1827-1832